Amarin Corporation (AMRN) Elects Joseph Kennedy as New Senior Vice President, General Counsel

December 19, 2011 4:41 PM EST
Amarin Corporation plc (Nasdaq: AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, today announced the appointment of Joseph T. Kennedy to the newly created position of Senior Vice President, General Counsel. Mr. Kennedy will report to Joseph S. Zakrzewski, Amarin's Chairman and Chief Executive Officer.

"On behalf of the Board of Directors, I am pleased to welcome Joe to the Amarin senior management team," stated Zakrzewski. "His broad and sophisticated experience in intellectual property matters, public company and pharmaceutical industry compliance, mergers and acquisitions and general corporate matters make Joe an ideal addition to Amarin at this critical development stage for the company."

"The progress Amarin has made with AMR101 over the last several years has been impressive, and I am delighted to join the Amarin management team at this exciting time for the company," said Mr. Kennedy. "I look forward to contributing my skill set to Amarin."


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes